ABSTRACT
At present, cancer is still one of the most serious threats to human health. Despite the wide application of multiple cancer therapies in clinical practice, the therapeutic effects of most cancers are still far from satisfactory. In recent years, the discovery of regulated cell death may be a good first step on the road to treat cancer. Ferroptosis is triggered by lipid peroxidation of unsaturated fatty acids in cell membrane catalyzed by iron ion. It has been widely concerned as an emerging target for cancer therapy. With the booming of biomedical nanotechnology, ferroptosis as an emerging therapeutic target has attracted extensive attention. Here, we review the advance on the intersection of ferroptosis and biomedical nanotechnology. First, the research background of ferroptosis and nano-preparation as well as the feasibility of ferroptosis-based nano-drug delivery systems (nano-DDS) for cancer treatment are presented and analyzed. Then, the strategies for inducing ferroptosis based on nano-DDS are summarized, mainly including: the promotion of Fenton reaction, the inhibition of glutathione peroxidase 4 (GPX-4) and the restriction of the cysteine-glutamate exchange transporter (system Xc-). Furthermore, the combination therapy strategies based on biomedical nanotechnology induced ferroptosis are also discussed. Finally, we shine the spotlight on the prospects and challenges of ferroptosis-based nanotherapeutics in clinical application.
ABSTRACT
Precise drug delivery to tumors with low system toxicity is one of the most important and challenging tasks for pharmaceutical researchers. Despite progress in the field of nanotherapeutics, the use of artificially synthesized nanocarriers still faces several challenges, including rapid clearance from blood circulation and limited capability of overcoming multiple physiological barriers, which hamper the clinical application of nanoparticle-based therapies. Since leukocytes (including monocytes/macrophages, neutrophils, dendritic cells and lymphocytes) target tumors and can migrate across physiological barriers, leukocytes are increasing utilized as carriers to transfer nanoparticles to tumors. In this review we specifically focus on the molecular and cellular mechanisms of leukocytes that can be exploited as a vehicle to deliver nanoparticles to tumors and summarize the latest research on how leukocytes can be harnessed to improve therapeutic end-points. We also discuss the challenges and opportunities of this leukocyte-derived nanoparticle drug delivery system.
ABSTRACT
@#Introduction: There is a growing concern in using zinc oxide nanoparticles (ZnO NPs) for medical devices as alternative options in reducing hospital-acquired infections (HAIs). The commensal HAIs; Staphylococcus aureus (S.aureus) infect patients and lead to increased rates of morbidity and mortality. This study aims to investigate the antibacterial action of ZnO NPs in three different shapes; nanorod, nanoflakes and nanospheres impregnated in low-density polyethylene (LDPE) against S.aureus ATCC 25923. Methods: The antibacterial efficiency of ZnO NPs was studied through two standard test methods included were based on Clinical Laboratory Standards Institute (CLSI) guidelines MO2-A11 under light conditions of 5.70 w/m2 and American standard test method (ASTM) E-2149. Results: Preliminary screening did show a significant growth inhibition against S.aureus with ZnO NPs nanorod and nanoflakes, approximately in 7 to 8 mm zones of inhibition. Further analysis using ASTM E-2149 in dynamic conditions revealed variable activity depending on incubation treatment periods. It demonstrated the ZnO NPs in nanoflakes and nanosphere shape showed better inhibition against S.aureus with maximum reduction (100%). The FESEM results strongly suggest that the structure of ZnO nanoflakes and nanosphere played an importance role in nanomaterial-bacteria interaction which consequently cause cell membrane damage. Additionally, the irradiation under light treatment also enhance the generation of ROS and free radicals which helps the bactericidal activity against S.aureus. Conclusion: This study provides new insights for the antibacterial action of ZnO NPs/LDPE thin films in future biomedical appliances to reduce HAIs risks.
ABSTRACT
@#Introduction: With the increasing clinical use of titanium dioxide nanoparticles (nano-TiO2), a better understanding of their safety in the human use is critical. The present study aims to review the potential application of nano-TiO2 as targeted cancer therapy based on their toxicity risk which highly dependent on their physio-chemical properties. Methods: This review was performed based on PRISMA-P protocol that begin with literature searching on the selected databases; PubMed, Springer Link, Science Direct and general search engine; Google Scholar from 2013 to 2018. Studies retrieved by the pre-determined keywords (titanium dioxide nanoparticles, toxicity, genotoxicity, cytotoxicity, targeted cancer therapy) that assessed toxicity risk of nano-TiO2 in cancer therapeutics were included. Results: The search retrieved 252 articles. Assessment of eligibility by application of inclusion criteria yielded 14 articles. Nano-TiO2 induced cytotoxicity and genotoxicity in dose and time-dependent manner killing the cancerous cells. All studies used primary particles size < 100 nm with mean of 39.38 and standard deviation of 30.47 which is lower than the mean denoting diameter distribution from selected studies are concentrated from the mean. Conclusion: This review suggest that TiO2 nanoparticles can be considered as an ideal candidate for drug-delivery vehicle for targeted cancer therapy by specifically tailored their physio-chemical properties of this nanoparticles according to desired target site and functions to ensure its optimal efficacy.